Draxis boosted by interim results for thrombosis imaging agent
This article was originally published in Clinica
Executive Summary
Draxis Health's genetically-engineered diagnostic imaging agent for deep vein thrombosis (DVT) has shown promising interim results in a Canadian Phase II study.